Skip to main content
OpenTrials

Clinical trial condition

Adenoviridae Infections

Explore clinical trials studying Adenoviridae Infections. Study availability and eligibility vary by location and protocol.

92 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Adenoviridae Infections trial results

Completed

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

NCT00711035

Conditions
Adenoviridae Infections, Adenovirus Infection, DNA Virus Infections, +6 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of Miami Coral Gables, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Hackensack University Bergen County, New Jersey, United States
View Trial Details
Completed

Study of a New MVA Vaccine for Hepatitis C Virus

NCT01296451

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom
  • John Radcliffe Hospital, Headley Way Headington, Oxford, United Kingdom
  • Wycombe Hospital, High Wycombe, Buckinghamshire High Wycombe, United Kingdom
View Trial Details
Completed

Study of a Novel Therapeutic Vaccine for Hepatitis C Virus

NCT01094873

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +10 more
Locations
  • Wellcome Clinical Research Facility, Queen Elizabeth's Hospital, University Hospital Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom
  • John Radcliffe Hospital, Headley Way Headington, Oxford, United Kingdom
View Trial Details
Completed

A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)

NCT01070407

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +10 more
Locations
  • Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom
  • Wellcome Clinical Research Facility, Queen Elizabeth's Hospital, University Hospital Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom
View Trial Details

Related conditions